Worldwide, an estimated 40 to 50 million patients with diabetes fast during Ramadan, including nearly one-half of those with type 1 diabetes and most of those with type 2 diabetes. 1, 3 The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes. Ramadan is a time of spiritual reflection and renewal for millions of Muslims worldwide, but for those living with diabetes, fasting presents unique challenges. Successfully navigating this holy month requires careful planning and a proactive approach to managing blood sugar levels. Individuals fasting during Ramadan are less likely to see their physicians before starting the fast and more likely to fast against medical advice. Hence, these individuals are at increased risk of hyperglycemia, hypoglycemia, and cardiovascular and renal complications. All diabetic patients who fast during Ramadan should undergo an evaluation 1 or 2 months before the start of Ramadan to determine their level of diabetes control and the presence of acute and chronic complications of diabetes and other comorbid conditions. According to the EPIDIAR (Epidemiology of Diabetes and Ramadan) study on 12,243 Muslims from 13 different countries, approximately 43% of Type 1 Diabetes patients and 79% of Type 2 Diabetes patients fast every year during Ramadan. For people with diabetes, fasting safely during Ramadan is crucial. Learn about the diabetes-related risks and tips on how to prepare for fasting. There are proven metabolic benefits of Ramadan fasting in healthy as well as diabetes patients. Given the propensity of acute metabolic derangements and medicine-related side-effects, patients with diabetes can be at significant health risk by fasting. For people with diabetes who choose to fast, Ramadan may also help to strengthen the therapeutic alliance with physicians and may help to improve general diabetes management. However, people with diabetes and Healthcare Professionals (HCPs) face challenges during Ramadan. Conclusion: Fasting Safely with Diabetes During Ramadan. Managing diabetes during Ramadan requires a thoughtful approach, balancing fasting glucose management with safe eating habits. By adopting diabetic fasting tips, monitoring blood sugar levels, and adjusting medications, individuals can fast safely while preserving their health. According to guidelines from 2016 on how to deal with the Ramadan fasting, Muslims with type 2 diabetes are advised to refrain from fasting if they are defined as high-risk, i.e., have exhibited unbalanced diabetes or suffered from severe hypoglycemia during the three months prior to the Ramadan, as well as Muslims with renal failure or who Fasting during Ramadan can affect your diabetes management. Talk to your doctor before Ramadan to adjust your medication. Test your blood sugar more often – it doesn't break your fast. Know the signs of hypos (low blood sugar) and treat them immediately if they occur, even if it means breaking This page has information for people living with diabetes who are thinking about fasting for Ramadan. Ramadan in 2025 will run from on or around Friday 28 February for 29 or 30 days, ending with Eid al-Fitr, a religious holiday celebrated by Muslims worldwide. Fasting the month of Ramadan is a fundamental religious practice performed by millions of Muslims every year. Fasting Ramadan has been shown to be associated with an increased risk of hypoglycemia and glycemic deterioration in some patients with diabetes, particularly type1 diabetes , . INTRODUCTION. Fasting the Holy month of Ramadan may be challenging for the people with diabetes and their care providers due to potentially increased risk of acute complications such as hypoglycemia, hyperglycemia, dehydration and probably diabetic ketoacidosis (DKA), although there is very little evidence that DKA is increased during Ramadan.1 Hence, in 2005, the first statement for Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan. Diabetes Res Clin Pract. 2018;135:218–226. doi: 10.1016/j.diabres.2017.11.027. Objective This systematic review and meta-analysis assess the effects of Ramadan fasting in adolescents with type 1 diabetes mellitus (T1DM), on blood sugar factors such as hemoglobin A1C and problems caused by its lack of control such as hypoglycemia and DKA, and metabolic outcomes. Methods Electronic databases including MEDLINE, Embase, and SINOMED were searched up to February 13, 2024 Fasting the Holy month of Ramadan may be challenging for the people with diabetes and their care providers due to potentially increased risk of acute complications such as hypoglycemia, hyperglycemia, dehydration and probably diabetic ketoacidosis (DKA), although there is very little evidence that DKA is increased during Ramadan. 1 Hence, in A study of the fasting diabetic patients during the month of Ramadan. Med J Malaysia. 1990 Mars;45(1):14–7. [Google Scholar] 11. Yarahmadi S, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. While most patients with diabetes fast Ramadan safely, some patients do face potentially life‑threatening complications, including hypoglycemia, hyperglycemia, dehydration, and ketoacidosis.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |